Riddl program - phase i

Other Transaction IDV Awarded Last action

Contract number
HR00112590142
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order
Not on record
IDV ceiling
$6,379,166.00
Contracting staff
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Advanced Research Projects Agency awarded an Other Transaction IDV to the University of Washington's Office of Sponsored Programs with a ceiling of $6,379,166 on May 5, 2025, to support the Rapid Inhibitor Discovery and Development Pipeline (RIDDL) Phase I program, which focuses on AI-enabled generation of genome editing inhibitors. This OT sits outside the FAR and is authorized under DARPA's Other Transaction authority. The University of Washington, a public research institution headquartered in Seattle, serves as the administrative gateway for the university's federal research portfolio and brings substantial research infrastructure and expertise in translational research and applied science to biotech-focused prototype development. The RIDDL program represents DARPA's investment in accelerating inhibitor discovery through artificial intelligence integration with genomic research capabilities, positioning the university's Office of Sponsored Programs as the contracting entity managing delivery and compliance across the institution's research mission.

Transactions

Action Obligated Date
Funding Only Action P00005 · Rapid inhibitor discovery and development pipeline (riddl) - rapid AI-engabled generation of genome editing inhibitors - P00005 (fully fund option 1, correct… $1,432,420
Other Administrative Action P00004 · Rapid inhibitor discovery and development pipleine (riddl program) $0
Exercise an Option P00003 $1,027,076
Other Administrative Action P00002 · Rapid inhibitor discovery and development pipeline (riddl program) $0
Funding Only Action P00001 $1,039,315
Original award $889,038

Subawards

Subcontractor Amount Awarded
Profluent Bio Inc. RIDDL PROGRAM - PHASE I Rapid AI-Enabled Generation of Genome Editing Inhibitors. $1,293,064

Quick answers

Who was awarded contract HR00112590142?

HR00112590142 was awarded to University Of Washington by Defense Advanced Research Projects Agency (Department of Defense) on May 5, 2025.

How much is contract HR00112590142 worth?

HR00112590142's own ceiling is $6,379,166.

Was contract HR00112590142 competed?

The extent of competition for HR00112590142 was competed.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV